We are live on ! Find out more
EIM

Essex Investment Management Portfolio holdings

AUM $632M
1-Year Est. Return 95.36%
This Fund
S&P 500
This Quarter Est. Return
+15.88%
1 Year Est. Return
+95.36%
3 Year Est. Return
+271.62%
5 Year Est. Return
+354.98%
10 Year Est. Return
+3,586.14%
AUM
$574M
AUM Growth
+$39M
Cap. Flow
-$18.7M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.53%
Holding
332
New
30
Increased
74
Reduced
75
Closed
30

Sector Composition

Rank Sector Weight
1 Industrials 27.35%
2 Technology 24.24%
3 Healthcare 22.49%
4 Financials 5.86%
5 Consumer Discretionary 5.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIR icon
51
Mirion Technologies
MIR
$3.81B
$3.89M 0.68%
351,478
+980
+0.3% +$10.3K
OCUL icon
52
Ocular Therapeutix
OCUL
$2.25B
$3.86M 0.67%
443,677
+1,168
+0.3% +$9.63K
CXDO icon
53
Crexendo
CXDO
$219M
$3.85M 0.67%
828,759
+776,102
+1,474% +$3.36M
MRC
54
DELISTED
MRC Global
MRC
$3.82M 0.67%
300,195
+1,063
+0.4% +$13.8K
AEM icon
55
Agnico Eagle Mines
AEM
$91.3B
$3.74M 0.65%
46,437
-2,510
-5% -$194K
GFF icon
56
Griffon
GFF
$4.79B
$3.7M 0.65%
52,861
+150
+0.3% +$9.94K
ADPT icon
57
Adaptive Biotechnologies
ADPT
$3.99B
$3.68M 0.64%
718,656
+94,831
+15% +$413K
GLDD
58
DELISTED
Great Lakes Dredge & Dock
GLDD
$3.66M 0.64%
347,517
+915
+0.3% +$8.51K
MYO icon
59
Myomo
MYO
$59M
$3.61M 0.63%
899,135
+257,749
+40% +$1.07M
TARS icon
60
Tarsus Pharmaceuticals
TARS
$3.04B
$3.59M 0.63%
+109,156
New +$3.07M
DCBO
61
Docebo
DCBO
$574M
$3.59M 0.63%
81,176
+21,407
+36% +$876K
TBCH
62
Turtle Beach Corp
TBCH
$233M
$3.55M 0.62%
231,502
+623
+0.3% +$9.09K
AQST icon
63
Aquestive Therapeutics
AQST
$543M
$3.52M 0.61%
707,078
+1,894
+0.3% +$7.37K
CRNT icon
64
Ceragon Networks
CRNT
$205M
$3.43M 0.6%
1,251,134
+3,370
+0.3% +$9.21K
ZS icon
65
Zscaler
ZS
$29.3B
$3.36M 0.58%
19,629
-898
-4% -$164K
XOM icon
66
ExxonMobil
XOM
$650B
$3.34M 0.58%
28,466
-3,453
-11% -$399K
BPMC
67
DELISTED
Blueprint Medicines
BPMC
$3.28M 0.57%
+35,461
New +$3.52M
BMI icon
68
Badger Meter
BMI
$3.85B
$3.26M 0.57%
14,947
-1,620
-10% -$325K
RVLV icon
69
Revolve Group
RVLV
$1.72B
$3.26M 0.57%
131,463
+78
+0.1% +$1.64K
FTDR icon
70
Frontdoor
FTDR
$5.91B
$3.25M 0.57%
67,824
+189
+0.3% +$8.2K
BWAY
71
Brainsway
BWAY
$681M
$3.21M 0.56%
695,522
+1,788
+0.3% +$6.58K
CVLG icon
72
Covenant Logistics
CVLG
$876M
$3.2M 0.56%
121,208
+318
+0.3% +$8.24K
EVR icon
73
Evercore
EVR
$11.6B
$3.14M 0.55%
12,407
+34
+0.3% +$8.09K
TILE icon
74
Interface
TILE
$2.23B
$3.11M 0.54%
163,957
+453
+0.3% +$7.81K
DIS icon
75
Walt Disney
DIS
$181B
$3.06M 0.53%
31,856
-1,599
-5% -$147K

Similar funds

Essex Investment Management's Q3 2024 Portfolio in Review

As of Q3 2024, Essex Investment Management held 332 positions worth $574M, up 7.3% from $535M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Essex Investment Management withdrew a net $18.7M in Q3 2024, closing 30 positions and reducing 75 holdings. Its most notable exit was Dynavax Technologies, an estimated $4.71M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Essex Investment Management opened a new position in Pfizer worth $4.37M.

  • Essex Investment Management's largest Q3 2024 buy was Pfizer: 150,992 shares worth $4.37M.
  • Essex Investment Management added most to Crexendo in Q3 2024, an estimated $3.36M increase.
  • Essex Investment Management's biggest Q3 2024 reduction was Apple, cutting an estimated $2.87M.
  • Essex Investment Management fully exited Dynavax Technologies in Q3 2024, selling an estimated $4.71M.
  • Essex Investment Management's ten largest holdings make up 17% of its $574M portfolio in Q3 2024.
  • Essex Investment Management opened 30 new positions and closed 30 in Q3 2024.
  • Essex Investment Management's portfolio value rose 7.3% quarter-over-quarter to $574M.

Based on Essex Investment Management's 13F filing for Q3 2024, filed 10 Oct 2024.